James Garner
Chief Executive Officer chez PERCHERON THERAPEUTICS LIMITED
Fortune : 88 631 $ au 31/03/2024
Profil
James Stuart Garner is currently the Chief Executive Officer, MD & Director at Percheron Therapeutics Ltd.
He is also a Member at the Australian Institute of Co. Directors.
Previously, he served as the Chief Executive Officer, MD & Executive Director at Kazia Therapeutics Ltd.
from 2016 to 2023.
He was also the Vice President-Clinical & Medical Affairs at TBG Diagnostics Ltd.
Additionally, he held the position of Vice President-Research & Development at Takeda Pharmaceuticals Australia Pty Ltd.
from 2009 to 2013.
Dr. Garner obtained a graduate degree and an MBA from The University of Queensland.
He also completed his undergraduate studies at University College London.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/08/2023 | 900 000 ( 0,10% ) | 48 735 $ | 31/03/2024 | |
KAZIA THERAPEUTICS LTD
0,33% | 01/05/2023 | 781 819 ( 0,33% ) | 39 896 $ | 30/11/2023 |
Postes actifs de James Garner
| Sociétés | Poste | Début |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Chief Executive Officer | 07/08/2023 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
Anciens postes connus de James Garner
| Sociétés | Poste | Fin |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Chief Executive Officer | 01/05/2023 |
| Takeda Pharmaceuticals Australia Pty Ltd. | Chief Tech/Sci/R&D Officer | 01/01/2013 |
| TBG DIAGNOSTICS LIMITED | Chief Tech/Sci/R&D Officer | 12/11/2008 |
Formation de James Garner
| The University of Queensland | Graduate Degree |
| University College London | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KAZIA THERAPEUTICS LIMITED | Health Technology |
| PERCHERON THERAPEUTICS LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
TBG Diagnostics Ltd.
 TBG Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia. | Health Technology |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
| Takeda Pharmaceuticals Australia Pty Ltd. |
